AxioMed

http://www.axiomed.com/

Last activity: 27.10.2024

Active

Categories: CareDevelopmentHealthTechIndustryITPlatformProductTechnology

Developer of spinal function products intended to provide spinal implants that will address the unmet needs of degenerative disc disease patients. The company's spinal function products that are freedom cervical disc and freedom lumbar disc help in spinal implants and disc replacement and it also offers expertise including early artificial disc development efforts, enabling the healthcare industry to advance the standard of care beyond fusion and first-generation artificial discs.

Facebook LinkedIn

Mentions

Overview

Location

United States, Massachusetts, Malden

Total raised

$30M

Investors 2

Date	Name	Website
Sign up to see	Sign up to see	Sign up to see
	KICVentures	kicventuresgroup.com

Funding Rounds 5

Date	Series	Amount	Investors
Sign up to see	Sign up to see	Sign up to see	Sign up to see
May 22, 2012	Series D round	$5M
Mar 1, 2011	Funding round	$500K
Jul 22, 2010	Funding round	$14.5M
Dec 1, 2009	Funding round	$6.4M

Mentions in press and media 30

Date	Title	Description
Sign up to see	Sign up to see	Sign up to see
Oct 22, 2024	Dr. Kingsley R. Chin: The Only Black CEO Leading a Successful Global Private Equity HealthTech Investment Firm Focused on Spine Surgery Technologies	Dr. Kingsley R. Chin, selected speaker alongside Caribbean Prime Ministers and leaders, at an Organization of American States event hosted by the Jamaican Embassy in Washington D.C Dr. Kingsley R. Chin, Founder, Chairman, and CEO of KIC Ven...
Oct 8, 2024	KIC Ventures Changing the Private Equity Paradigm: The HealthTech Investment Firm with the Most Majority-Owned Portfolio of Revenue-Generating Spine Companies	KIC Ventures, the private healthtech investment firm with the most majority-owned portfolio of spine companies KIC Ventures is transforming the private equity landscape in healthtech by focusing exclusively on spine surgery technologies and...
Mar 11, 2024	Artificial Disc Replacement (ADR) Market Predicted to Garner $1.3 Bn by 2030 \| CAGR of 12.3% \| Vantage Market Research	Vantage Market Research Artificial Disc Replacement Market Size, Share, Industry Trends, Growth, and Opportunities Analysis by 2030 WASHINGTON, D.C, DISTRICT OF COLUMBIA, UNITED STATES, March 11, 2024 /EINPresswire.com/ -- The Global Artifi...
Sep 14, 2022	Dr. Kingsley R Chin Granted Patent To Add Wireless Sensor To AxioMed’s Total Disc Replacement To Target $23.50B Smart Medical Device Market	AxioMed's Patent To Add Wireless Sensors issued in 2020 The patent provided a sensing artificial disc core having a top surface, a bottom surface, and at least one sidewall: at least one sensor disposed in or on the resilient core and a wir...
Aug 8, 2022	AxioMed LLC Submits Final Module III to the FDA Becoming the First and Only Lumbar Viscoelastic Total Disc Replacement Company to Complete a USA IDE Clinical Trial	KICVentures Group portfolio company AxioMed has the only Lumbar Viscoelastic Disc Replacement Medical Device in the USA with global clinical use since 2008 and no device failure “We are preparing to begin training surgeons early 2023 in ant...
Apr 18, 2022	AxioMed Announces Progress with Completing Module I-III Lumbar FDA Submission of The First Lumbar Viscoelastic Disc Replacement to Complete a US IDE Clinical Study	KICVentures Group portfolio company AxioMed has the only Lumbar Viscoelastic Disc Replacement Medical Device in the USA in clinical use since 2008 "The current ball and socket disc designs on the market are seeing superior results over...
Dec 1, 2021	AxioMed LLC Reports Landmark Filing of Initial PMA Module to FDA as the First Viscoelastic Lumbar Artificial Disc Replacement to Complete an IDE Clinical Study	AxioMed Freedom Lumbar Artificial Disc L4-L5 "Patients, Key Opinion Leaders (KOLs), and investment analysts recognize disc replacements as the future of spine treatments, and thus companies lacking disc replacements should be concerned...
Sep 18, 2021	AxioMed LLC, A KICVentures Group Portfolio Company, Achieved Landmark Patent For Lateral Lumbar Viscoelastic Disc Replacement Medical Device	KICVentures Group portfolio company AxioMed achieved Patent For Lateral Lumbar Viscoelastic Disc Replacement Medical Device there is a sense of urgency in commercializing the AxioMed cervical, lumbar and lateral lumbar viscoelastic disc rep...
Jan 11, 2013	Funding: AxioMed Spine raises $3.6M	Medical device company AxioMed Spine Corp., has raised $3.6 million from current and new investors. The Ohio-based spinal orthopedics company’s devices focus on restoring spinal function to treat degenerative spine diseasea,according to a p...
Jan 10, 2013	AxioMed Spine Grabs $3.6M	GARFIELD HEIGHTS, OHIO, Spinal orthopedics company raised $3.6 million from current and new investors. >> Click here for more funding data on AxioMed Spine >> To export AxioMed Spine funding data to PDF and Excel, click here...
Jan 10, 2013	Artificial spinal disc maker AxioMed wraps up pivotal study and pulls in $3.6 million	A second product, the Freedom Cervical Disc, is the focus of an EU study that’s set to begin enrolling patients soon, Baty said. The new round of financing saw participation from existing investors as well as a few new investors. It follows...
Jan 10, 2013	AxioMed Spine Raises $3.6M in Funding	AxioMed Spine Corp., a Cleveland, Ohio-based spinal orthopedics company, raised $3.6m in funding. Backers included existing and new investors. Led by Patrick McBrayer, President and Chief Executive Officer, and James Kuras, Chief Operating ...
May 22, 2012	AxioMed Spine Raises $5M in Series D Financing	AxioMed Spine Corporation, a Garfield Heights, Ohio-based spinal orthopedics company, has raised $5m in Series D financing. The funding, which augments the previously announced $15m Series D round, was provided by current and new investors....
Nov 7, 2011	Medical devices: Four tips on navigating the European regulatory environment	Europe’s “no walk in the park”: It’s a “misconception” that it’s a quicker process to obtain the EU’s CE Mark over the FDA’s 510(k) clearance, according to Ray Ursick, president of regulatory consulting group REU Associates. “If you think i...
Mar 6, 2011	AxioMed Spine Receives $500,000 from the State of Ohio	AxioMed Spine, a Cleveland, OH-based company that develops products for restoring spinal function to patients with degenerative spine disease, received $500,000 from the State of Ohio. The company will use the funds to manufacture and launc...
Mar 1, 2011	AxioMed Spine gets $500K state loan to help launch new product	The loan was recommended by a group associated with the Ohio Department of Development and is pending approval from the State Controlling Board. AxioMed hopes to obtain European regulatory clearance, called the CE Mark, to commercialize its...
Jul 22, 2010	AxioMed Spine raises $14.5M for U.S. spinal disc study, EU launch	“We are fortunate to have supportive, high-caliber investors and the opportunity to add new investors to form a consortium with the ability to fund our product development programs,” Patrick McBrayer, the company’s president and CEO, said i...
Jul 22, 2010	AxioMed pulls in $14.5 million to fund U.S. spinal disc study	By Mary Vanac AxioMed Spine Corp. raised $14.5 million in Series D funding to help the company finish enrolling patients for a pivotal U.S. clinical study of its lumbar disc replacement and earn CE Mark approval for its cervical disc in Eur...
Jul 22, 2010	AxioMed Spine Corporation Raises $14.5M	AxioMed Spine Corporation, a Garfield Heights, Ohio-based company focused on the development of products designed to restore function in patients with degenerative spine disease, has raised $14.5m. The funding, from both current and new inv...
Dec 1, 2009	AxioMed Spine Corp. raises $6.4 million to continue developing spinal disc replacements	In May, the company won the CE Marking, which enables it to sell its disc replacements inÂ Europe. At that time, AxioMedÂ planned to introduce its lumbar spine disc replacement toÂ the 27 European Union countries. It has introduced Freedom ...
May 12, 2009	AxioMed Spine Corp. earns coveted CE Marking to sell disc replacement in Europe	AxioMed on Tuesday said it has receivedÂ Europe’s CE Marking — much like Food and Drug Administration market clearance in the United States. The company plans in the fall to introduce its lower-spine disc replacement, which uses a rubberize...
Jan 17, 2009	Health care leads 2008 Northeast Ohio investments	That was down from nearly three-quarters of $318 million inÂ venture investments made in the region’s health care companies in 2007, according to that year’s venture capital report. The task force, which includes development organizationsÂ ...
	AxioMed Spine Corp. raises $6.4 million to continue developing spinal disc replacements	GARFIELD HEIGHTS, Ohio — AxioMed Spine Corp. has completed the firstÂ part of its thirdÂ financing round, raisingÂ $6.4 million fromÂ “leading venture capital firms,” which were not named. The company that is developingÂ next-generation spi...
	Health care leads 2008 Northeast Ohio investments	Health-care companies in Northeast Ohio garnered the lion’s share of investor dollars last year, according to the 2008 Venture Capital Report for the so-called Cleveland Plus region, made up of Akron, Canton, Cleveland and Youngstown. Healt...
	Artificial spinal disc maker AxioMed wraps up pivotal study and pulls in $3.6 million	As it finishes up a pivotal study to support an application to the U.S. Food and Drug Administration for marketing clearance of its first product, medical device company AxioMed Spine Corp. has brought in $3.6 million in fresh capital. The ...
	AxioMed Spine Corp. earns coveted CE Marking to sell disc replacement in Europe	Updated 8:38 p.m. GARFIELD HEIGHTS, Ohio –Â This fall, AxioMed Spine Corp. in suburban Cleveland couldÂ start selling for the first time its spinal disc replacementÂ after winning regulatory approval in Europe. AxioMed on Tuesday said it ha...
	AxioMed Spine raises $14.5M for U.S. spinal disc study, EU launch	AxioMed Spine Corp. has raised $14.5 million in Series D funding to help the Garfield Heights, Ohio company finish enrolling patients for a pivotal U.S. clinical study of its lumbar disc replacement, as well as earn CE Mark approval for its...
	Medical devices: Four tips on navigating the European regulatory environment	The medical device industry seems to be in love with Europe. Due to complaints about the U.S. Food and Drug Administration’s perceived inconsistency, risk aversion and foot-dragging, many in the device industry have turned to the European U...
	AxioMed Spine gets $500K state loan to help launch new product	A $500,000 loan from the state of Ohio will help AxioMed Spine manufacture and launch the company’s second product, an artificial cervical spine disc. The company will use the loan to purchase machinery and equipment to manufacture the disc...

Reviews 0

FAQ about AxioMed

How much funding has AxioMed raised?

AxioMed has raised $30M in total across 5 funding rounds.

What funding rounds has AxioMed raised?

Parsers VC lists 5 funding rounds of AxioMed, among them a Series D round of $5M on May 22, 2012, a funding round of $500K on Mar 1, 2011 and a funding round of $14.5M on Jul 22, 2010.

Who has invested in AxioMed?

Parsers VC lists 2 investors of AxioMed, among them KICVentures.

What has the press written about AxioMed?

Parsers VC has collected 30 articles mentioning AxioMed, among them “Dr. Kingsley R. Chin: The Only Black CEO Leading a Successful Global Private Equity HealthTech Investment Firm Focused on Spine Surgery Technologies” (Oct 22, 2024) and “KIC Ventures Changing the Private Equity Paradigm: The HealthTech Investment Firm with the Most Majority-Owned Portfolio of Revenue-Generating Spine Companies” (Oct 8, 2024).

Is AxioMed still active?

Yes, AxioMed is active; its latest activity on Parsers VC dates from Oct 27, 2024.